Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens

British Journal of Pharmacology

Volumn 118, Issue 6, 1996, Pages 1523-1529

  Sum, Chi Shing ^a   Wan, David C C ^a   Cheung, Wing Tai ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Angiotensin II; AT1 receptor; CGP 42112; Losartan; Purinergic transmission; Rat vas deferens

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN III; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NORADRENALIN; PURINE RECEPTOR; RESERPINE;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS;

EID: 0029977179     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15569.x     Document Type: Article

References (32)

1. BOUSCAREL, B., WILSON, P.B., BLACKMORE, P.F., LYNCH, C.J. EXTON, J.H. (1988). Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes. J. Biol. Chem., 263, 14920-14924.
2. BROWN, D.A., DOCHERTY, J.D., FRENCH, A.M., MACDONALD, A., McGRATH, J.C. & SCOTT, N.C. (1983). Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br. J. Pharmacol., 79, 379-393.
3. DONOSO, M.V. & HUIDOBRO-TORO, J.P. (1989). Involvement of postjunctional purinergic mechanisms in the facilitatory action of bradykinin in neurotransmission in the rat vas deferens. Eur. J. Pharmacol., 160, 263-273.
4. ELLIS, J.L. & BURNSTOCK, G. (1989). Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea pig vas deferens. Br. J. Pharmacol., 97, 1157-1164.
5. GILLESPIE, J.S. & McGRATH, J.C. (1974). The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat anococcygeus muscle and vas deferens. Br. J. Pharmacol., 52, 585-590.
6. HEDGE, S.S. & CLARKE, D.E. (1993). Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit. J. Pharmacol. Exp. Ther., 265, 601-608.
7. HUIDOBRO-TORO, J.P. & PARADA, S. (1988). Co-transmission in the rat vas deferens postjunctional synergism of noradrenaline and adenosine 5′-triphosphate. Neurosci. Lett., 85, 339-344.
8. KAKAR, S.S., SELLERS, J.C., DEVOR, D.C., MUSGROVE, L.C. & NEILL, J.D. (1992). Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun., 183, 1090-1096.
9. KREGE, J.H., JONH, S.W.M., LANGENBACH, L.L., HODGIN, J.B., HAGAMAN, J.R., BACHMAN, E.S., JENNETTE, J.C., O'BRIEN, D.A. & SMITHIES, O. (1995). Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature, 375, 146-148.
10. LEE, C.M. & CHEUNG, W.T. (1989). Effects of α,β-methylene ATP on potentiation of contractions to field stimulation of rat vas deferens by carbachol. Acta Pharmacol. Sin., 10, 17-22.
11. McGRATH, J.C. (1978). Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single stimulus. J. Physiol., 283, 23-39.
12. ONDETTI, M.A., RUBIN, B. & CUSHMAN, D.W. (1977). Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science, 196, 441-444.
13. PEACH, M.J. (1977). Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev., 51, 313-370.
14. PHILLIPS, M.I. (1987). Functions of angiotensin in the central neurons system. Ann. Rev. Physiol., 49, 413-435.
15. REAGAN, L.P., YE, X., MAREFZSKI, C.H. & FLUHARTZ, S.J. (1993). Down-regulation of angiotensin II receptor subtypes and desensitization of cyclic GMP production in neuroblastoma N1E-115 cells. J. Neurochem., 60, 24-31.
16. REGOLI, D., PARK, W.K. & RIOU, F. (1974). Pharmacology of angiotensin. Pharmacol. Rev., 26, 69-123.
17. 1 receptor antagonist. Regul. Pept., 50, 137-145.
18. ROHDE, G.C., VENEZIAN, E. & HUIDOBRO-TORO, J.P. (1986). Asymmetric distribution of purinergic and adrenergic neurotransmission cooperates in the motor activity along the rat vas deferens. Neurosci. Lett., 71, 197-202.
19. SASAMURA, H., HEIN, L., KRIEGER, J.E., PRATT, R.E., KOBVILKA, B.K. & DZAU, V.J. (1992). Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem. Biophys. Res. Commun., 185, 253-259.
20. x. Pharmacol. Rev., 9, 242-246.
21. SNEDDON, P. & MACHALY, M. (1992). Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J. Autonom. Pharmacol., 12, 421-428.
22. SNELL, R.S. (1992). Clinical Neuroanatomy for Medical Students. 3rd Ed. pp. 505-506. Boston: Little, Brown and Company.
23. 6 angiotensin II. Biochemistry. Biophys. Res. Commun., 169, 977-1006.
24. STORY, D.F. & ZIOGAS, J. (1987). Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol. Sci., 8, 269-271.
25. SUM, C.S. & CHEUNG, W.T. (1995). Characterization of contractile response to angiotensin in epididymal rat vas deferens. Pharmacol., 51, 105-111.
26. SUMNERS, C., TANG, W., ZELEZAA, B. & RAIZADA, M.K. (1991). Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neuron and astrocytes from rat brain. Proc. Natl. Acad. Sci. U.S.A., 88, 7567-7571.
27. TANABE, N., UENO, A. & TSUJIMOTO, G. (1993). Angiotensin II receptors in the rat urinary bladder smooth muscle: Type 1 subtype receptors mediate contractile responses. J. Urol., 150, 1056-1059.
28. TIMMERMANS, P.B.W.M., WONG, P.C., CHIU, A.T., HERBLIN, W.F., BENFIELD, P., CARINI, D.J., LEE, R.J., WEXLER, R.R., SAVE, J.A. & SMITH, R.D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251.
29. TRACHTE, G.J. (1988). Angiotensin effects on vas deferons adrenergic and purinergic neurotransmission. Eur. J. Pharmacol., 146, 261-269.
30. WEIHPRECHT, H., LORENZ, J.N., BRIGGS, J.P. & SCHNERMANN, J. (1994). Synergistic effects of angiotensin and adenosine in the renal microvasculature. Am. J. Physiol., 266, F227-F239.
31. ZHANG, J.S., VAN MEEL, J.C.A., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1993). Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein. Naunyn-Schmied. Arch. Pharmacol., 347, 220-224.
32. ZIMMERMAN, B.G. (1981). Adrenergic facilitation by angiotensin: does it serve a physiological function? Clinical Sci.. 60, 343-348.